Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 20.40M | £ 15.60M | £ 16.20M | £ 17.10M | £ 18.00M |
Total Assets | £ 765.90M | £ 749.70M | £ 745.60M | £ 746.80M | £ 773.20M |
Total Debt | £ 225.60M | £ 226.60M | £ 229.90M | £ 323.50M | £ 299.50M |
Net Debt | £ 205.20M | £ 211.00M | £ 213.70M | £ 306.40M | £ 281.50M |
Total Liabilities | £ 308.80M | £ 300.50M | £ 304.50M | £ 367.30M | £ 372.10M |
Stockholders Equity | £ 457.10M | £ 449.20M | £ 441.10M | £ 379.50M | £ 401.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |